Back to Search
XAVIER JIMENEZ, M.D.
M.D.
Psychiatry Physician
NPI: 1881907756IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
MT197696(PA)
Education
OTHER
Class of 2008
Research & Publications (20)
A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3.
PMID 15767551·Mol Cancer Ther·2005
7-preclinical
Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody.
PMID 19484148·Neoplasia·2009
7-preclinical
Generation and characterization of a therapeutic human antibody to melanoma antigen TYRP1.
PMID 18334748·Hum Antibodies·2007
7-preclinical
An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody.
PMID 17462601·Biochem Biophys Res Commun·2007
7-preclinical
Single variable domain antibody as a versatile building block for the construction of IgG-like bispecific antibodies.
PMID 17126853·J Immunol Methods·2007
7-preclinical
Genetic effects on obesity assessed by bivariate genome scan: the Mexican-American coronary artery disease study.
PMID 16899800·Obesity (Silver Spring)·2006
8-other
Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
PMID 17085673·Clin Cancer Res·2006
7-preclinical
Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2.
PMID 16682007·Biochem Biophys Res Commun·2006
7-preclinical
Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies.
PMID 16481314·J Biol Chem·2006
7-preclinical
Cell-based selection of internalizing fully human antagonistic antibodies directed against FLT3 for suppression of leukemia cell growth.
PMID 15931264·Leukemia·2005
8-other
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target.
PMID 15767546·Mol Cancer Ther·2005
7-preclinical
A genome-wide scan for carotid artery intima-media thickness: the Mexican-American Coronary Artery Disease family study.
PMID 15692111·Stroke·2005
8-other
Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2.
PMID 15223651·Leuk Lymphoma·2004
7-preclinical
Conservation of receptor antagonist anti-tumor activity by epidermal growth factor receptor antibody expressed in transgenic corn seed.
PMID 15598988·Hum Antibodies·2004
7-preclinical
Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C.
PMID 15150322·J Cell Sci·2004
4-observational
Coronary vasomotor abnormalities in insulin-resistant individuals.
PMID 15126253·Ann Intern Med·2004
3-trial
The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody.
PMID 15120630·Biochem Biophys Res Commun·2004
8-other
Simultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody.
PMID 14576153·J Biol Chem·2004
8-other
A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
PMID 14695208·Cancer Res·2003
7-preclinical
Di-diabody: a novel tetravalent bispecific antibody molecule by design.
PMID 12969563·J Immunol Methods·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3811 OHARA ST
PITTSBURGH, PA 15213 - Phone
- (412) 586-9181
Quick Facts
- NPI
- 1881907756
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile